Display Settings:

Format

Send to:

Choose Destination

    Bioorg Med Chem Lett. 2009 Feb 1;19(3):654-7. Epub 2008 Dec 24.

    The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors.

    Simons LJ, Caprathe BW, Callahan M, Graham JM, Kimura T, Lai Y, LeVine H 3rd, Lipinski W, Sakkab AT, Tasaki Y, Walker LC, Yasunaga T, Ye Y, Zhuang N, Augelli-Szafran CE.

    Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Rd., Ann Arbor, MI 48105, USA.

    It is believed that beta-amyloid aggregation is an important event in the development of Alzheimer's disease. In the course of our studies to identify beta-amyloid aggregation inhibitors, a series of N-phenyl anthranilic acid analogs were synthesized and studied for beta-amyloid inhibition activity. The synthesis, structure-activity relationship, and in vivo activity of these analogs are discussed.

    PMID: 19121939 [PubMed - in process]

    Supplemental Content

    Click here to read